Monika Schmelz, PhD

Professor, Pathology
Professor, Applied BioSciences
Associate Professor, BIO5 Institute

Address:

PO Box 245043
Building: Arizona Health Sciences Center (#201)
Room #: 5212A

Phone:

520-626-8864

Email:

schmelz@email.arizona.edu

Education:

Karl Ruprecht University of Heidelberg, 1982 (M.S., Biology)
German Cancer Research Center,1989 (Ph.D., Cell & Tumor Biology)

Research Activities:

Mechanism of Lymphoma

Selected Publications:

2017

Kendrick S, Rimsza LM, Scott DW, Slack GW, Farinha P, Tan KL, Persky D, Puvvada S, Connors JM, Sehn L, Gascoyne RD, Schmelz M. Aberrant cytoplasmic expression of MHCII confers worse progression free survival in diffuse large B-cell lymphoma. Virchows Archiv, 2017, Vol 470 (1), 113-117. (DOI: 10.1007/s00428-016-2041-7 [1]; PMID: 27888357). http://link.springer.com/article/10.1007/s00428-016-2041-7 [2]

2016

Puvvada SD, Li H, Rimsza LM, Bernstein SH, Fisher RI, LeBlanc M, Schmelz M, Glinsmann-Gibson B, Miller TP, Maddox AM, Friedberg JW, Smith SM, Persky DO. A phase II study of belinostat (PXD101) in relapsed and refractory aggressive B-cell lymphomas: SWOG S0520. See comment in PubMed Commons belowLeukemia & Lymphoma, 2016 Jan 12:1-11. [Epub ahead of print].

Redd L, Schmelz M, Burack R, Cook JR, Day AW, Rimsza LM. Langerhans Cell Histiocytosis (LCH) shows distinct cytoplasmic expression of the major histocompatibility class II antigen (MHCII) in LCH. J. Hematopathology, 2016, 9: 107-112. DOI 10.1007/s12308-016-0272-9. (http://link.springer.com/search?sortOrder=newestFirst&facet-content-type=Article&facet-journal-id=12308 [3]).

Havas AB, Rodrigues KB, Bhakta A, Demirjian JA, Hahn S, Tran J, Scavello M, Tula-Sanchez AA, Zeng Y, Schmelz M, Smith CL. Belinostat and vincristine demonstrate mutually synergistic cytotoxicity associated with mitotic arrest and inhibition of polyploidy in a preclinical model of aggressive diffuse large B cell lymphoma. Cancer Biology & Therapy 2016, Vol 0, No. 0, 1-13. (http://dx.doi.org/10.1080/15384047.2016.1250046 [4]).

2012

Schmelz M, Montes-Moreno S, Piris MA, Wilkinson ST, Rimsza LM. Lack and/or aberrant localization of major histocompatibility Class II (MHCII) protein in plasmablastic lymphoma [5]. Haematologica 97(10):1614-6; 2012.

2010

Jensen, V., A. R. Prasad, A. Smith, M. Raju, C. S. Wendel, M. Schmelz, W. Leyva, J. Warneke, and R. S. Krouse, "Prognostic criteria for squamous cell cancer of the skin.", J Surg Res, vol. 159, issue 1, pp. 509-16, 2010 Mar. PMID: 19375720 [6]

2009

Thai, H. M., E. Juneman, J. Lancaster, T. Hagerty, R. Do, L. Castellano, R. Kellar, S. Williams, G. Sethi, M. Schmelz, et al., "Implantation of a three-dimensional fibroblast matrix improves left ventricular function and blood flow after acute myocardial infarction.", Cell Transplant, vol. 18, issue 3, pp. 283-95, 2009. PMCID: PMC2739416 [7] PMID: 19558777 [8]

2007

Li, L., M. Schmelz, E. M. Kellner, J. N. Galgiani, and M. J. Orbach, "Nuclear labeling of Coccidioides posadasii with green fluorescent protein.", Ann N Y Acad Sci, vol. 1111, pp. 198-207, 2007 Sep. PMID: 17344520 [9]

2006

Kremer, C. L., M. Schmelz, and A. E. Cress, "Integrin-dependent amplification of the G2 arrest induced by ionizing radiation.", Prostate, vol. 66, issue 1, pp. 88-96, 2006 Jan 1. PMCID: PMC2732347 [10] PMID: 16114062 [11]

2005

Li, L., S. M. Dial, M. Schmelz, M. A. Rennels, and N. M. Ampel, "Cellular immune suppressor activity resides in lymphocyte cell clusters adjacent to granulomata in human coccidioidomycosis.", Infect Immun, vol. 73, issue 7, pp. 3923-8, 2005 Jul. PMCID: PMC1168614 [12] PMID: 15972478 [13]